Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 6794848, 7 pages
http://dx.doi.org/10.1155/2016/6794848
Clinical Study

Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status

Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea

Received 22 December 2015; Accepted 7 February 2016

Academic Editor: Tatsuya Toyokawa

Copyright © 2016 Ju Seok Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Nakamura, T. Matsumoto, M. Iida, T. Yao, and M. Tsuneyoshi, “Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends,” Cancer, vol. 97, no. 10, pp. 2462–2473, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Weber, M. A. Dimopoulos, D. P. Anandu, W. C. Pugh, and G. Steinbach, “Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori,” Gastroenterology, vol. 107, no. 6, pp. 1835–1838, 1994. View at Google Scholar · View at Scopus
  3. F. Siavoshi, R. Malekzadeh, M. Daneshmand, and H. Ashktorab, “Helicobacter pylori endemic and gastric disease,” Digestive Diseases and Sciences, vol. 50, no. 11, pp. 2075–2080, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Stolte, E. Bayerdörffer, A. Morgner et al., “Helicobacter and gastric MALT lymphoma,” Gut, vol. 50, no. 3, pp. 19–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Dreyling, C. Thieblemont, A. Gallamini et al., “Esmo consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma,” Annals of Oncology, vol. 24, no. 4, pp. 857–877, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ruskoné-Fourmestraux, W. Fischbach, B. M. P. Aleman et al., “EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT,” Gut, vol. 60, no. 6, pp. 747–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Steinbach, R. Ford, G. Glober et al., “Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial,” Annals of Internal Medicine, vol. 131, no. 2, pp. 88–95, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Ruskoné-Fourmestraux, A. Lavergne, P. H. Aegerter et al., “Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment,” Gut, vol. 48, no. 3, pp. 297–303, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Nakamura, T. Matsumoto, H. Suekane et al., “Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori,” Gut, vol. 48, no. 4, pp. 454–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Rohatiner, F. d'Amore, B. Coiffier et al., “Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma,” Annals of Oncology, vol. 5, no. 5, pp. 397–400, 1994. View at Google Scholar · View at Scopus
  11. A. Zullo, C. Hassan, L. Ridola et al., “Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review,” Journal of Clinical Gastroenterology, vol. 47, no. 10, pp. 824–827, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Nakamura, T. Sugiyama, T. Matsumoto et al., “Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan,” Gut, vol. 61, no. 4, pp. 507–513, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Zucca, C. Copie-Bergman, U. Ricardi, C. Thieblemont, M. Raderer, and M. Ladetto, “Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 24, no. 6, Article ID mdt343, pp. 144–148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Sumida, Y. Kitadai, T. Hiyama et al., “Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma,” Cancer Science, vol. 100, no. 6, pp. 1075–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Akamatsu, T. Mochizuki, Y. Okiyama, A. Matsumoto, H. Miyabayashi, and H. Ota, “Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection,” Helicobacter, vol. 11, no. 2, pp. 86–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. S. Kim, S. J. Chung, Y. S. Choi et al., “Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease,” British Journal of Cancer, vol. 96, no. 9, pp. 1324–1328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. C. Wotherspoon, “Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori,” Annual Review of Medicine, vol. 49, pp. 289–299, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Takenaka, K. Yokota, M. Mizuno et al., “Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori,” Helicobacter, vol. 9, no. 3, pp. 194–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Nakamura, T. Matsumoto, H. Suekane et al., “Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment,” Cancer, vol. 104, no. 3, pp. 532–540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. L.-T. Chen, J.-T. Lin, J. J. Tai et al., “Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma,” Journal of the National Cancer Institute, vol. 97, no. 18, pp. 1345–1353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Nakamura, M. Seto, M. Tajika et al., “Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status,” The American Journal of Gastroenterology, vol. 103, no. 1, pp. 62–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Zullo, C. Hassan, F. Cristofari et al., “Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma,” Clinical Gastroenterology and Hepatology, vol. 8, no. 2, pp. 105–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Sackmann, A. Morgner, B. Rudolph et al., “Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging,” Gastroenterology, vol. 113, no. 4, pp. 1087–1090, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Wündisch, C. Thiede, A. Morgner et al., “Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication,” Journal of Clinical Oncology, vol. 23, no. 31, pp. 8018–8024, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Andriani, A. Miedico, L. Tedeschi et al., “Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study,” Digestive and Liver Disease, vol. 41, no. 7, pp. 467–473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Psyrri, S. Papageorgiou, and T. Economopoulos, “Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management,” Annals of Oncology, vol. 19, no. 12, pp. 1992–1999, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. G. Gobbi, F. Corbella, F. Valentino et al., “Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy,” Annals of Oncology, vol. 20, no. 3, pp. 465–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Raderer, A. Chott, J. Drach et al., “Chemotherapy for management of localisd high-grade gastric B-cell lymphoma: how much is necessary?” Annals of Oncology, vol. 13, no. 7, pp. 1094–1098, 2002. View at Publisher · View at Google Scholar · View at Scopus